EyeCyte
La Jolla, California, United States
About EyeCyte
EyeCyte, Inc. is working with Pfizer's Bioinnovation and io therapeutics Center and The Scripps Research Institute to develop novel therapeutics to treat neovascular and degenerative retinal disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2008)
- Website: eyecyte.com
- Phone: 858-453-5800
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eyecyte-2508295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.